August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sakditad Saowapa: Sunvozertinib Gains FDA Approval for Metastatic NSCLC
Aug 6, 2025, 08:05

Sakditad Saowapa: Sunvozertinib Gains FDA Approval for Metastatic NSCLC

Sakditad Saowapa, Hematology-Oncology Fellow at the University of Iowa, shared a post on LinkedIn:

“FDA Accelerated Approval (2 Jul 2025)

Sunvozertinib (Zegfrovy) approved for metastatic NSCLC with EGFR exon 20 insertion after platinum chemotherapy.
  • WU-KONG1B trial (n=85)
  • ORR: 46% (95% CI: 35–57%)
  • DoR: 11.1 months (95% CI: 8.2–NE)
  • Companion Diagnosis: Oncomine Diagnosis Express Test
  • Warnings: ILD/pneumonitis, GI, skin, ocular, embryo-toxic.”

Read further.

Sakditad Saowapa: Sunvozertinib Gains FDA Approval for Metastatic NSCLC

More posts featuring Sakditad Saowapa.